Adar1 Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Adar1 Capital Management, LLC

  • $615 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$143.31 - $247.0 $25.6 Million - $44 Million
-178,295 Reduced 98.97%
1,850 $450 Million
Q1 2024

May 15, 2024
BUY
$146.51 - $198.2 $25 Million - $33.8 Million
170,645 Added 1796.26%
180,145 $26.9 Billion
Q4 2023

Feb 14, 2024
BUY
$151.41 - $196.57 $1.44 Million - $1.87 Million
9,500 New
9,500 $1.82 Billion

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email